<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000662464">
  <TermName>CP regimen</TermName>
  <TermPronunciation>(… REH-jih-men)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A chemotherapy combination used to treat chronic lymphocytic leukemia (CLL). It includes the drugs chlorambucil hydrochloride and prednisone. Also called chlorambucil-prednisone, chlorambucil-prednisone regimen, and CP.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000726244" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;CP regimen&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000726245" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen CP&quot;" language="es" id="_4"/>
  <SpanishTermName>régimen CP</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento de  la leucemia linfocítica crónica. Incluye los medicamentos clorhidrato de clorambucilo y prednisona. También se llama clorambucilo y prednisona, CP y régimen de clorambucilo y prednisona.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2010-04-23</DateFirstPublished>
  <DateLastModified>2010-12-28</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000686550" url="/about-cancer/treatment/drugs/CHLORAMBUCIL-PREDNISONE">CHLORAMBUCIL-PREDNISONE</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
